PDPL Intraday Analysis...

PDPL Share Price

Open 26.00 Change Price %
High 26.00 1 Day 0.65 2.60
Low 24.65 1 Week 4.65 22.14
Close 25.65 1 Month -0.55 -2.10
Volume 25133 1 Year -13.55 -34.57
52 Week High 82.65
52 Week Low 19.30
PDPL Important Levels
Resistance 2 26.90
Resistance 1 26.39
Pivot 25.43
Support 1 24.91
Support 2 24.40
NSE INDIA Most Active Stocks
HCC 40.55 -0.86%
HCC 40.55 -0.86%
VISESHINFO 0.30 0.00%
SBIN 254.10 -0.61%
ASHOKLEY 74.70 -3.68%
IDFCBANK 66.85 -1.69%
ADANIPOWER 29.15 0.17%
UNITECH 4.75 -5.00%
JPASSOCIAT 7.55 -2.58%
IDEA 73.45 0.89%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.20 33.33%
SPYL 2.00 17.65%
AUSOMENT 26.25 16.41%
AURIONPRO 116.40 15.48%
SHYAMTEL 33.30 15.22%
PARRYSUGAR 50.75 13.79%
NICCO 0.55 10.00%
TFL 11.00 10.00%
LYCOS 8.95 9.82%
DATAMATICS 88.10 9.71%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
SRGINFOTEC 0.25 -16.67%
RAJRAYON 0.25 -16.67%
DBL 224.55 -11.61%
DBL 224.55 -11.61%
DBL 224.55 -11.61%
BLUECHIP 0.40 -11.11%
REIAGROLTD 0.45 -10.00%
NAKODA 0.45 -10.00%
REISIXTEN 0.55 -8.33%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 4
As on 2nd Dec 2016 PDPL Share Price closed @ 25.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 36.76 & Sell for SHORT-TERM with Stoploss of 25.93 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for December
1st Target up-side 29.1
2nd Target up-side 32.04
3rd Target up-side 34.98
1st Target down-side 20.7
2nd Target down-side 17.76
3rd Target down-side 14.82
PDPL Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 61.10 Sideways
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is 93.77 Sideways
WILLIAM %R (14) William %R is -33.85 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 20.59
10 Day Avg Volume Traded -49.52 % Less then 10 Day Average Volume
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.